Canadian Diabetes Assocation Clinical Practice Guidelines Pancreas and Islet Cell Transplant Chapter 20 Breay W. Paty, Angela Koh, Peter Senior.

Slides:



Advertisements
Similar presentations
Chapter 38 Stewart B. Harris, Onil Bhattacharyya,
Advertisements

Organization of Diabetes Care Chapter 6 Maureen Clement, Betty Harvey, Doreen M Rabi, Robert S Roscoe, Diana Sherifali Canadian Diabetes Association 2013.
Susan Alexander, DNP, CNS, CRNP, BC- ADM College of Nursing University of Alabama in Huntsville Clinical Affiliation: Outpatient Diabetes Self-Management.
Methods Chapter 2 Gillian Booth, Alice YY Cheng Canadian Diabetes Association 2013 Clinical Practice Guidelines.
Canadian Diabetes Association Clinical Practice Guidelines Retinopathy Chapter 30 Shelley R. Boyd, Andrew Advani, Filiberto Altomare, Frank Stockl.
Canadian Diabetes Association Clinical Practice Guidelines Hypoglycemia Chapter 14 Dale Clayton, Jean-François Yale, Vincent Woo.
Guidelines.diabetes.ca | BANTING ( ) | diabetes.ca Copyright © 2013 Canadian Diabetes Association The Essentials Canadian Diabetes Association.
Diabetes.ca | BANTING ( ) Canadian Diabetes Association Clinical Practice Guidelines Type 2 Diabetes in Children and Adolescents Chapter 35.
Canadian Diabetes Association Clinical Practice Guidelines Pregnancy
Canadian Diabetes Association Clinical Practice Guidelines Weight Management in Diabetes Chapter 17 Sean Wharton, Arya M. Sharma, David C.W. Lau.
Canadian Diabetes Association Clinical Practice Guidelines Natural Health Products in Type 2 Diabetes Chapter 21 Richard Nahas, Jeannette Goguen.
Canadian Diabetes Association Clinical Practice Guidelines Diabetes in the Elderly Chapter 37 Graydon S. Meneilly, Daniel Tessier, Aileen Knip.
Canadian Diabetes Association Clinical Practice Guidelines Pharmacologic Management of Type 2 Diabetes Chapter 13 William Harper, Maureen Clement, Ronald.
Screening for Type 1 and Type 2 Diabetes Chapter 4 Jean-Marie Ekoé, Zubin Punthakee, Thomas Ransom, Ally PH Prebtani, Ron Goldenberg Canadian Diabetes.
Bariatric Surgery vs. Intensive Medical Therapy in Obese Diabetic Patients: 3-Year Outcome Bariatric Surgery vs. Intensive Medical Therapy in Obese Diabetic.
Canadian Diabetes Association Clinical Practice Guidelines Chronic Kidney Disease in Diabetes Chapter 29 Phil McFarlane, Richard E. Gilbert, Lori MacCallum,
Canadian Diabetes Association Clinical Practice Guidelines Acute Coronary Syndromes and Diabetes Chapter 26 Jean-Claude Tardif, Phillipe L. L’Allier, David.
Canadian Diabetes Association Clinical Practice Guidelines Monitoring for Glycemic Control Chapter 9 Lori Berard, Ian Blumer, Robyn Houlden, David Miller,
Diabetes and Mental Health Chapter 18 David J. Robinson, Meera Luthra, Michael Vallis Canadian Diabetes Association 2013 Clinical Practice Guidelines.
Prolonged Diabetes Reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates Hering et al, Nature.
Canadian Diabetes Association Clinical Practice Guidelines In-Hospital Management of Diabetes Chapter 16 Robyn Houlden, Sara Capes, Maureen Clement, David.
Canadian Diabetes Assocaition Clinical Practice Guidelines Pharmacotherapy in Type 1 Diabetes Chapter 12 Angela McGibbon, Cindy Richardson, Cheri Hernandez,
Canadian Diabetes Association Clinical Practice Guidelines Dyslipidemia Chapter 24 G. B. John Mancini, Robert A. Hegele, Lawrence A. Leiter.
UCHSC Renal and Islet Transplantation in Diabetes Alex Wiseman, M.D. Director, Renal Transplant Clinic University of Colorado Health Sciences Center.
Why Surgical Treatment of Diabetes May Not be a Good Option McGill First Canadian Summit on Surgery for Type 2 Diabetes Montréal, Québec May 7, 2010 David.
Canadian Diabetes Association Clinical Practice Guidelines Treatment of Hypertension Chapter 25 Richard E. Gilbert, Doreen Rabi, Pierre LaRochelle, Lawrence.
Canadian Diabetes Association Clinical Practice Guidelines Neuropathy Chapter 31 Vera Bril, Bruce Perkins, Cory Toth.
Canadian Diabetes Association Clinical Practice Guidelines Screening for the Presence of Coronary Artery Disease Chapter 23 Paul Poirier, Robert Dufour,
Canadian Diabetes Association 2013 Clinical Practice Guidelines Targets for Glycemic Control Chapter 8 S. Ali Imran, Rémi Rabasa-Lhoret, Stuart Ross.
Canadian Diabetes Association Clinical Practice Guidelines Vascular Protection in People with Diabetes Chapter 22 James A. Stone, David Fitchett, Steven.
Canadian Diabetes Association Clinical Practice Guidelines Erectile Dysfunction Chapter 33 Gerald Brock, William Harper.
Canadian Diabetes Association Clinical Practice Guidelines Treatment of Diabetes in People with Heart Failure Chapter 28 Jonathan G. Howlett, John C. MacFadyen.
Canadian Diabetes Association Clinical Practice Guidelines Management of Stroke in Diabetes Chapter 27 Michael Sharma, Gord Gubitz.
Reducing the Risk of Developing Diabetes Chapter 5 Thomas Ransom, Ronald Goldenberg, Amanda Mikalachki, Ally PH Prebtani, Zubin Punthakee Canadian Diabetes.
The Role of Pancreas Transplantation in the Long Term Management of Diabetes Christopher Johnson MD Professor of Surgery Division of Transplant Surgery.
Canadian Diabetes Association Clinical Practice Guidelines Physical Activity and Diabetes Chapter 10 Ronald J Sigal, Marni J Armstrong, Pam Colby, Glen.
N212: Health Differences Across the Life Span 2
diasoce3.ppt1 Why is the current therapy not perfect?  Even slightly elevated blood glucose is harmful.  The limiting factor of insulin treatment.
Pancreatic and Islet Cell Transplantation. GENERAL PRINCIPLES Pancreas graft survival rates have significantly improved over the past decade, and now.
CARE OF PATIENTS WITH DIABETES MELLITUS JANNA WICKHAM RN MSN LSSC FALL 2013 Chapter 20.
David C. Mulligan, MD, FACS
Dr. Charu Kartik Senior Clinical Dietitian KFSH&RC,Riyadh Dr. Charu Kartik Senior Clinical Dietitian KFSH&RC,Riyadh NUTRITIONAL CO-MORBITIES POST RENAL.
Glycemic Control in Simultaneous Islet-Kidney Versus Pancreas-Kidney Transplantation in Type 1 Diabetes: A Prospective 13-Year Follow-up Featured Article:
The ADVANCE trial: update and new results Jean-François Gautier Saint Louis Hospital, Paris 12 th Meeting of the Mediterranean Group for the Study of Diabetes.
Effect of Hypertension and Dyslipidemia on glycemic control among Type 2 Diabetes patients in Thailand Dr. Mya Thandar DrPH Batch 5 1.
3 Patrick T Anderson, 2,3 Vivian McAlister, 1,3 Alp Sener, 1,3 Patrick P Luke Divisions of 1 Urology and 2 Surgery, Department of Surgery, 3 Schulich School.
DIABETES IN THE ELDERLY 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada.
A Diabetes Outcome Progression Trial
Guidelines.diabetes.ca | BANTING ( ) | diabetes.ca Copyright © 2013 Canadian Diabetes Association The Essentials Canadian Diabetes Association.
RETINOPATHY 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada.
Type 1 Diabetes Type 1 diabetes or “insulin dependent” diabetes is an autoimmune disease that results in destruction of insulin-producing beta cells of.
An initiative of South Asian Federation of Endocrine Societies (SAFES)
Diabetes And Hemodialysis 1 Dr.Ruba Nashawati. 2.
Islet cell transplantation Rob Crookston. Advanced Nurse Practitioner. Oxford University Hospitals NHS Foundation Trust.
Philip R. Schauer, M.D., Deepak L. Bhatt, M.D., M.P.H., John P. Kirwan, Ph.D., Kathy Wolski, M.P.H., Stacy A. Brethauer, M.D., Sankar D. Navaneethan, M.D.,
Guidelines.diabetes.ca | BANTING ( ) | diabetes.ca Copyright © 2013 Canadian Diabetes Association CHOICE OF AGENT AFTER INITIAL METFORMIN.
Treatment of Pancreatitis MLTTP (case study)
Optimal Blood Glucose Monitoring
Recommendation In people with clinical cardiovascular disease in whom glycemic targets are not met, a SGLT2 inhibitor with demonstrated cardiovascular.
 Title: POST RENAL TRANSPLANT DIABETIC NEPHROPATHY By:Ayman Maher Nagib, Yasser Elsayed Matter, Mohamed Megahed Aboulmagd, Osama Ashry Gheith, Ayman.
Beta Cell Transplantation Richard Smith Consultant Senior Lecturer
Stephen Sekoulopoulos and Dr. Jaimie Nathan
Empagliflozin (Jardiance®)
Volume 83, Issue 3, Pages (March 2013)
GLP-1 Receptor Agonists: A Tool for the Primary Care Physician to Reduce CV Risk in Diabetes?
Patient characteristics: American vs Canadian transplant patients
MSCs in the DRI BioHUB Strategy
Why is the current therapy not perfect?
Adiponectin hypothesis for insulin resistance, the metabolic syndrome, and atherosclerosis Takashi Kadowaki, et al. J. Clin. Invest :
Comparison of the regression lines for AIRarg (the acute insulin response to intravenous arginine over 2–5 min after injection) and AIRargMAX (the response.
Presentation transcript:

Canadian Diabetes Assocation Clinical Practice Guidelines Pancreas and Islet Cell Transplant Chapter 20 Breay W. Paty, Angela Koh, Peter Senior

guidelines.diabetes.ca | BANTING ( ) | diabetes.ca Copyright © 2013 Canadian Diabetes Association 2013 Key Points 1.Simultaneous pancreas-kidney transplant in T1DM and ESRD can improve kidney graft survival 2.Successful pancreas or islet allotransplantation may result in insulin independence in patients with T1DM and potential macro- and microvascular benefits 3.There are risks associated with these procedures and thus the risk-benefit ratio must be weighed for each patient individually

guidelines.diabetes.ca | BANTING ( ) | diabetes.ca Copyright © 2013 Canadian Diabetes Association Co-existing Renal Disease Simultaneous kidney-pancreas transplant in patients with T1DM and ESRD can improve renal graft survival If considered for renal transplant Consider for simultaneous pancreas transplant

guidelines.diabetes.ca | BANTING ( ) | diabetes.ca Copyright © 2013 Canadian Diabetes Association Pancreatic or Islet Transplant may Restore Endogenous Insulin Secretion Reduction of diabetes related complications Islet cell transplant May stabilize microvascular disease Pancreatic Transplant Improved microvascular outcomes, lipids, blood pressure & carotid intimal media thickness Restoration of endogenous insulin secretion Improvement in A1C Reduction/elimination of hypoglycemia Pancreatic transplant/islet auto-transplant NOTE: Insufficient data on overall patient survival with transplant.

guidelines.diabetes.ca | BANTING ( ) | diabetes.ca Copyright © 2013 Canadian Diabetes Association Pancreas Graft Survival Based on Type of Transplant 1 Transplant Type1 year5 years10 years15 years Simultaneous pancreas kidney 83%69%51%33% Pancreas after kidney74%45%24%13% Pancreas alone78%54%28%9% 1.Waki K, Kadowaki T. An analysis of long-term survival from the OPTN/UNOS Transplant Registry. Clin Transplant. 2007: Ryan EA, Paty BW, Senior PA, et al. Five year follow-up after clinical islet transplantation. Diabetes. 2005;54: Islet Transplantation: Insulin Independence Rate 2 Transplant Type1 year5 years10 years15 years Islet allotransplantation70%10%NA

guidelines.diabetes.ca | BANTING ( ) | diabetes.ca Copyright © 2013 Canadian Diabetes Association RisksIsletPancreas ProceduralMinor Procedural Risk (<10%): Intraperitoneal hemorrhage Partial portal vein thrombosis Gallbladder puncture Major Surgical Risk: Graft Thrombosis Hemorrhage Pancreatitis Wound Infection Peripancreatic abscess Duodenal stump leakage ImmunosuppressionLifelong Risks Associated with Procedures

guidelines.diabetes.ca | BANTING ( ) | diabetes.ca Copyright © 2013 Canadian Diabetes Association 1. Individuals with T1DM and ESRD who are being considered for kidney transplantation, should also be considered for simultaneous pancreas transplantation [Grade D, Level 4] Recommendation 1

guidelines.diabetes.ca | BANTING ( ) | diabetes.ca Copyright © 2013 Canadian Diabetes Association Recommendation 2 2.Individuals with T1DM and preserved renal function, or who have undergone successful kidney transplantation, but have persistent metabolic instability characterized by severe glycemic lability and/or severe hypoglycemia despite best efforts to optimize glycemic control, may be considered for pancreas or islet allotransplantation [Grade D, Consensus]

guidelines.diabetes.ca | BANTING ( ) | diabetes.ca Copyright © 2013 Canadian Diabetes Association 2013 Recommendation 3 3.Individuals undergoing total pancreatectomy for benign pancreatic disease may be considered for islet auto-transplantation, but only in an experienced islet transplantation centre [Grade D, Consensus]

guidelines.diabetes.ca | BANTING ( ) | diabetes.ca Copyright © 2013 Canadian Diabetes Association CDA Clinical Practice Guidelines – for professionals BANTING ( ) – for patients